Related Experiment Video
Updated: Jan 26, 2026

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
Published on: October 16, 2015
Methodology of drug screening and target identification for new necroptosis inhibitors
Pengchao Pan1, Zhenyu Cai2, Chunlin Zhuang3
1Department of Pharmaceutical Analysis, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China.
Abstract:
Apoptosis has been considered as the only form of regulated cell death for a long time. However, a novel form of programmed cell death called necroptosis was recently reported. The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human diseases. Thus, the study on the molecular mechanism of necroptosis and its effective inhibitors has been an attractive field for researchers. Herein, we introduce the molecular mechanism of necroptosis and focus on the literature about necroptosis drug screening in recent years. In addition, the identification of the critical drug targets of the necroptosis is also discussed.
Insights
Necroptosis, a programmed cell death form, is crucial in human diseases. This study reviews necroptosis mechanisms, recent drug screening efforts, and identifies key drug targets for therapeutic development.
Area of Science:
- Cellular Biology
- Molecular Biology
- Pathology
Background:
- Apoptosis was long considered the sole regulated cell death pathway.
- Necroptosis is a newly identified form of programmed cell death.
- Necroptosis significantly contributes to human disease pathogenesis.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying necroptosis.
- To review recent advancements in necroptosis drug screening.
- To identify critical therapeutic targets for necroptosis.
Main Methods:
- Literature review of molecular mechanisms.
- Analysis of recent drug screening studies.
- Discussion of necroptosis target identification.
Main Results:
- Detailed overview of necroptosis molecular pathways.
- Summary of identified necroptosis inhibitors and screening strategies.
- Highlighting key molecular targets for drug development.
Conclusions:
- Necroptosis is a vital regulated cell death process implicated in various diseases.
- Targeting necroptosis pathways offers promising therapeutic strategies.
- Further research into necroptosis inhibitors and targets is warranted.
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

